These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Rajagopalan S; Mohler ER; Lederman RJ; Mendelsohn FO; Saucedo JF; Goldman CK; Blebea J; Macko J; Kessler PD; Rasmussen HS; Annex BH Circulation; 2003 Oct; 108(16):1933-8. PubMed ID: 14504183 [TBL] [Abstract][Full Text] [Related]
4. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation? Lekas M; Lekas P; Latter DA; Kutryk MB; Stewart DJ Curr Opin Cardiol; 2006 Jul; 21(4):376-84. PubMed ID: 16755208 [TBL] [Abstract][Full Text] [Related]
5. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Hedman M; Hartikainen J; Syvänne M; Stjernvall J; Hedman A; Kivelä A; Vanninen E; Mussalo H; Kauppila E; Simula S; Närvänen O; Rantala A; Peuhkurinen K; Nieminen MS; Laakso M; Ylä-Herttuala S Circulation; 2003 Jun; 107(21):2677-83. PubMed ID: 12742981 [TBL] [Abstract][Full Text] [Related]
7. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. Su H; Lu R; Kan YW Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13801-6. PubMed ID: 11095751 [TBL] [Abstract][Full Text] [Related]
8. [Therapeutic angiogenesis for ischemic heart disease by transplantation of bone marrow cells]. Matsubara H Nihon Rinsho; 2003 Apr; 61 Suppl 4():698-703. PubMed ID: 12735052 [No Abstract] [Full Text] [Related]
9. [The latest review of therapeutic angiogenesis using angiogenic growth factors to peripheral arterial diseases]. Aoki M; Ogihara T; Morishita R Nihon Rinsho; 2002 Sep; 60(9):1845-55. PubMed ID: 12233086 [TBL] [Abstract][Full Text] [Related]
10. Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trial. Rajagopalan S; Mohler E; Lederman RJ; Saucedo J; Mendelsohn FO; Olin J; Blebea J; Goldman C; Trachtenberg JD; Pressler M; Rasmussen H; Annex BH; Hirsch AT; Am Heart J; 2003 Jun; 145(6):1114-8. PubMed ID: 12796772 [TBL] [Abstract][Full Text] [Related]
11. Non-viral vectors for gene therapy: clinical trials in cardiovascular disease. Shah PB; Losordo DW Adv Genet; 2005; 54():339-61. PubMed ID: 16096018 [TBL] [Abstract][Full Text] [Related]
12. A balancing act: therapeutic approaches for the modulation of angiogenesis. Springer ML Curr Opin Investig Drugs; 2006 Mar; 7(3):243-50. PubMed ID: 16555684 [TBL] [Abstract][Full Text] [Related]
13. [Therapeutic angiogenesis through intramuscular injection of the gene for vascular endothelial growth factor (VEGF)]. Banga JD Ned Tijdschr Geneeskd; 2000 Jan; 144(3):113-6. PubMed ID: 10674116 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic angiogenesis: a case for targeted, regulated gene delivery. Webster KA Crit Rev Eukaryot Gene Expr; 2000; 10(2):113-25. PubMed ID: 11186327 [TBL] [Abstract][Full Text] [Related]
15. Effective treatment of vascular endothelial growth factor refractory hindlimb ischemia by a mutant endothelial nitric oxide synthase gene. Qian HS; Liu P; Huw LY; Orme A; Halks-Miller M; Hill SM; Jin F; Kretschmer P; Blasko E; Cashion L; Szymanski P; Vergona R; Harkins R; Yu J; Sessa WC; Dole WP; Rubanyi GM; Kauser K Gene Ther; 2006 Sep; 13(18):1342-50. PubMed ID: 16642030 [TBL] [Abstract][Full Text] [Related]
16. Gene therapy progress and prospects: therapeutic angiogenesis for ischemic cardiovascular disease. Vincent KA; Jiang C; Boltje I; Kelly RA Gene Ther; 2007 May; 14(10):781-9. PubMed ID: 17476300 [TBL] [Abstract][Full Text] [Related]
17. Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector. Magovern CJ; Mack CA; Zhang J; Hahn RT; Ko W; Isom OW; Crystal RG; Rosengart TK Ann Thorac Surg; 1996 Aug; 62(2):425-33; discussion 433-4. PubMed ID: 8694601 [TBL] [Abstract][Full Text] [Related]
18. Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb? Francis SC; Raizada MK; Mangi AA; Melo LG; Dzau VJ; Vale PR; Isner JM; Losordo DW; Chao J; Katovich MJ; Berecek KH Physiol Genomics; 2001 Dec; 7(2):79-94. PubMed ID: 11773594 [TBL] [Abstract][Full Text] [Related]
19. Angiogenesis and gene therapy in man: dream or reality? Amant C; Berthou L; Walsh K Drugs; 1999; 59 Spec No():33-6. PubMed ID: 10548390 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic neovascularization for ischemic heart disease. Lekas M; Kutryk MJ; Latter DA; Stewart DJ Can J Cardiol; 2004 Aug; 20 Suppl B():49B-57B. PubMed ID: 15309206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]